RobertA.BurgerMD
Obstetrics & Gynecology • Philadelphia, PAGynecologic Oncology
Director of Clinical Research and Gynecologic Oncology Fellowship Program, University of Pennsylvania
Dr. Burger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Blvd.
3rd Floor West
Philadelphia, PA 19104Phone+1 215-662-3318Fax+1 215-349-5849- Is this information wrong?
Education & Training
University of California (Irvine)Fellowship, Gynecologic Oncology, 1992 - 1996
University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1988 - 1992
New York University School of MedicineClass of 1988
Harvard UniversityAB, Biochemistry, Cum Laude, 1980 - 1984
Certifications & Licensure
CA State Medical License 1991 - 2021
PA State Medical License 1991 - 2020
NV State Medical License 1998 - 2003
TX State Medical License 1997 - 2000
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2012-2014
- America's Top Doctors Castle Connolly, 2012-2014
- America's Top Doctors for Cancer Castle Connolly, 2012-2013
- Join now to see all
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
- Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
- Join now to see all
Publications & Presentations
PubMed
- Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/EN...Pothuri, B., Han, S., Chase, D., Heitz, F., Burger, R., Gaba, L., Van Le, L., Guerra, E., Bender, D., Korach, J., Cloven, N., Churruca, C., Follana, P., DiSilvestro, P...> ;Gynecologic Oncology. 2024 Feb 6
- Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncolo...Robert F Ozols, Brian N Bundy, Benjamin E Greer, Jeffrey M Fowler, Daniel Clarke-Pearson, Robert A Burger, Robert S Mannel, Koen DeGeest, Ellen M Hartenbach, Rebecca B...> ;Journal of Clinical Oncology. 2023 Sep 1
- Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma.Lori Cory, Colleen Brensinger, Robert A Burger, Robert L Giuntoli 2nd, Mark A Morgan, Nawar Latif, Lilie L Lin, Emily M Ko> ;Gynecologic Oncology Reports. 2022 Feb 1
- Join now to see all
Grant Support
- Angiogenesis Targeted Therapeutics Of Ovarian CancerNational Cancer Institute2001–2006
- Core--Clinical Research OfficeNational Cancer Institute2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
